APA (7th ed.) Citation

H, O., K, T., W, H., Y, T., T, K., D, S., . . . M, Y. (2025). Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma. Molecular and cellular biology, 45(2), 79. https://doi.org/10.1080/10985549.2024.2438817

Chicago Style (17th ed.) Citation

H, Oshikiri, et al. "Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma." Molecular and Cellular Biology 45, no. 2 (2025): 79. https://doi.org/10.1080/10985549.2024.2438817.

MLA (9th ed.) Citation

H, Oshikiri, et al. "Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma." Molecular and Cellular Biology, vol. 45, no. 2, 2025, p. 79, https://doi.org/10.1080/10985549.2024.2438817.